Aigen Investment Management, LP

Position in NVS — Novartis AG

CIK 1741224 NEW YORK, NY

Position in NVS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$351,522

+$118,562 QoQ

Shares Held

2,243

-6.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#1,049

of 1,603 holders

Holding Since

Mar 2021

5 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Aigen Investment Management, LP holds $6,988,444 across 5 Drug Manufacturers - General names. NVS ranks #5 (5.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	29,983	$3,788,052
2	LLY	ELI LILLY & Co	1,102	$1,321,771
3	JNJ	Johnson & Johnson	3,601	$914,545
4	SNY	Sanofi	14,359	$612,554
5	NVS	Novartis AG This page	2,243	$351,522

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$351,522	2,243	-6.3%	Shares	Sole	2026-08-14
2024-12-31	$232,960	2,394	-91.1%	Shares	Sole	2025-02-06
2021-12-31	$2,353,380	26,905	-49.7%	Shares	Sole	2022-02-11
2021-09-30	$4,371,631	53,456	+1608.4%	Shares	Sole	2021-11-12
2021-03-31	$267,466	3,129	—	Shares	Sole	2021-05-11
No filing history on record for this holder in this stock.